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.2012.07.0Abstract The current study aims to assess the community pharmacist’s skills to make correct use
of metered dose inhalers (MDIs). Seventy-four pharmacists were approached using six clusters from
the most populous areas of Alahsa, Eastern region Saudi Arabia. Of whom n= 71, responses were
taken in consideration to perform the statistical analysis. Scoring of pharmacist demonstration was
done using a nine-step checklist for the appropriate use of inhaler. A simulated patient approach
was used to assess pharmacist’s skill. Majority, 98.6% of the pharmacists were Egyptian nationals
with a mean age of 38.74 ± SD 4.52. Overall, pharmacists were found to have a poor recognition
(mean score = 4.2 ± SD 2.08) with the steps considered while using an inhaler. However, signiﬁ-
cantly better knowledge differences were observed among the pharmacists aged 30–35 years
(5.52 ± 2.14, t= 2.851, p= 0.009*). In addition, job experience (3–4 years) was found signiﬁcantly
(p= 0.003*) associated with a better knowledge toward the appropriate use of inhaler. It was seen
that the young pharmacists working on chain pharmacies have comparatively better knowledge
than the other groups.
ª 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Asthma is one of the chronic lung conditions affecting more
than 300 million people worldwide. So far, there is no ultimate30610419.
(T.M. Khan).
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04cure for asthma, except to manage it symptomatically. Negli-
gence in this regard aggravates the symptoms that result
approximately in 200,000 deaths annually (Khaled et al.,
2008). For the symptomatic management of asthma the appro-
priate use of an inhaler is the key factor. However, in the case
of improper use, patients will not receive the appropriate dose
of the drug and will result in poor outcome (Giraud and
Roche, 2002; Fink and Rubin, 2005). In the current practice
community pharmacists have a major role in counseling pa-
tients about the appropriate use of drugs (Ballantyne, 2007).
Particularly for asthmatic patients, pharmacists can easily
identify a patient with un-control due to poor inhalation tech-
nique (Ekedahl, 1996; Cordina and McElnay, 2001). However,ier B.V. All rights reserved.
Table 1 Demographic information of respondents.
Demographic N (%)
Nationality
Egyptian 70 (98.6%)
Saudi 1 (1.4%)
Pharmacy type
Chain pharmacy 37 (52.1%)
Individual/independent pharmacy 34 (47.9%)
Educational proﬁle
Bachelor of Pharmacy 71 (100.0%)
Age [range 30–48 years]
Mean age = 38.74 ± 4.52
30–35 Years 21 (29.6%)
36–40 Years 28 (39.4%)
41–45 Years 16 (22.5%)
46–48 Years 6 (8.5%)
Job experience
3–4 Years 5 (7.06%)
5–6 Years 8 (11.3%)
7–8 Years 18 (25.4%)
9–10 Years 40 (56.3%)
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Many pharmacists lack the skills essential to demonstrate the
correct use of metered dose inhalers (MDIs) (Kesten et al.,
1993; Cain et al., 2001). To ensure the appropriate use of
MDIs, one should follow the nine steps essential for ensuring
the delivery of the exact dose to the lungs (Khaled et al.,
2008). It is the job of pharmacists to master these nine steps
and educate the patients through systematic demonstration
to ensure the expected outcomes (Cordina and McElnay,
2001; Basheti et al., 2005). In case the pharmacists have a poor
knowledge about these critical steps, the patient will remain
deprived of the exact inhalation technique that will assist asth-
ma control. Therefore, it is very essential to evaluate the com-
munity pharmacist’s knowledge about the basic steps to use an
inhaler.
Particularly, seeing the situation in Saudi Arabia, asthma is
a common respiratory problem. Environmental condition,
exposure to tobacco smoke and indoor pets are the common
factors contributing to asthma among Saudi youth (Al Frayh
et al., 2001). In terms of access to health care facilities, all the
Saudi nationals are entitled for a free treatment at the public
hospitals. However, still many visit private hospitals or pur-
chase their medicines from the individual and chain pharma-
cies. In the recent two decades, a massive growth is seen in
the Saudi community pharmacy business. In year 1985, there
were 1233 community pharmacies in Saudi Arabia, which
jumped to 3244 in year 2001 (TA, 2003). The current number
might be higher than these, of which 835 pharmacies are
owned by individuals and rest are the chain pharmacies that
have branches throughout Saudi Arabia. At the moment, Sau-
di community pharmacy is facing three main challenges; one is
the shortage of human resource (pharmacist), two is the non-
prescription sale of medicines and three most of the commu-
nity pharmacy owners are non-pharmacist businessmen who
have more interest in cash than in the national drug policies(Al-Mohamadi et al., 2011; Bawazir, 2005). Among these,
the non-prescription sale of medicines is under spotlight for
couple of years. It might be possible that many community
pharmacists are dispensing MDIs to consumers without a
prescription. However, no one has ever evaluated the commu-
nity pharmacist’s knowledge about the critical steps involved
while using a metered dose inhaler. In addition, the knowledge
about the inhaler technique is found to be declined if not re-
viewed on a routine basis (Skaer et al., 1996). Therefore, the
current study aims to evaluate the community pharmacist’s
knowledge about the appropriate use of MDIs in the Eastern
Region, Alahsa, Saudi Arabia.
2. Method
A cross-sectional study was planned among the clustered com-
munity pharmacies in the Eastern region, Al-Ahsa (AH). AH
is the major urban center in the eastern region of the Kingdom.
The period of this study was from 1st March 2012 to 15th
April 2012. A simulated patient approach was used to assess
pharmacist’s knowledge for the adequate use of inhalers.
2.1. Study sample
In order to draw a representative sample of community phar-
macists from AH, a survey was done to estimate the number of
pharmacies in the region. A total of 150 pharmacies were iden-
tiﬁed in the AH region, of these about 100 were in the urban
areas and the rest were in the rural areas. Keeping in view
the population facts, six clusters were deﬁned and 71 pharma-
cists were approached. Of these, 31 were independent pharma-
cies owned by a single owner and the rest 40 were from the two
main chain pharmacies in the region.
2.2. Simulated patients
A simulated patient approach was used to evaluate the com-
munity pharmacist knowledge about the appropriate use of
MDIs. Simulated patients group was comprised of six students
from the second year, Doctor of Pharmacy (Pharm D) batch,
College of Clinical Pharmacy, King Faisal University. These
students were trained for the role-playing session (counseling
for asthmatic patient for inhaler use) for the ﬁnal year student
in the pharmaceutical care lab practical (scheduled during the
study period).
2.3. Assessment of the pharmacist’s knowledge about
appropriate use of MDIs
The assessment of the pharmacist was done using criteria for
using MDIs as listed in the Guidelines for the Diagnosis and
Management of Asthma, National Asthma Education and
Prevention Program (Basheti et al., 2005) Detailed steps en-
listed in this guideline are as follows;
s Shake the inhaler and remove the cap.*
s Breathe out slowly and completely.
s Hold the inhaler in upright position.
s Insert the mouthpiece into mouth between closed lips.*
s Depress the canister once. . .*
Table 2 Pharmacist demonstration about the critical steps while using inhalers.
Steps for using inhalers % Pharmacist demonstrating
these steps
% Pharmacist not demonstrating
these steps
1-Shake the inhaler and remove the cap 42.25 57.75
2-Breathe out slowly and completely 29.58 70.42
3-Hold the inhaler in upright position 69.01 30.99
4-Insert the mouthpiece into mouth between closed lips 74.65 25.35
5-Depress the canister once. . . 66.20 33.8
6- At the same time breathe in slowly for deep inhalation 45.07 54.93
7-Remove the inhaler with closed lips 57.75 42.25
8-Hold your breath for 5–10 s 25.35 74.65
9-Wait for 20–30 before starting the second puﬀ 18.31 81.69
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Upon the selection, a group of two students entered the
pharmacy. One pretended to be an asthma patient, while other
pretended as his friend. The simulated patient entered the
pharmacy pretending as an asthma patient. In ﬁrst step, the
simulated patient told the pharmacist that he is recently diag-
nosed asthmatic and is not aware of the exact procedure to use
a metered dose inhaler (MDI). Meanwhile the simulated pa-
tient also tries to socialize with the pharmacist in order to
know his demographic information, educational background
and years of experience as shown in Table 1. All the informa-
tion was noted by the second student using the spreadsheet on
the smart phone.
In the second step, the pharmacist’s counseling session
about inhaler was assessed using the nine item criteria. When
the pharmacist explains the procedure to the simulated patient,
the second student who is pretending as his friend marks the
steps missed by the pharmacist during the session. Upon the
demonstration of every right step, one mark was given to the
pharmacist and in the case, he missed a step or demonstration
was wrong was graded as zero.Table 3 Mean score comparison among the groups.
Variable Mean score
Age
30–35 Years 5.52 ± 2.14
36–40 Years 4.12 ± 2.04
41–45 Years 3.40 ± 1.40
46–48 Years 2.33 ± 0.81
Job experience
3–4 Years 6.80 ± 1.92
5–6 Years 4.87 ± 1.72
7–8 Years 4.98 ± 2.41
9–10 Years 3.35 ± 1.51
Pharmacy type
Chain pharmacy 4.48 ± 2.10
Individual pharmacy 3.88 ± 2.04
* Signiﬁcant, ANOVA, Student t-test.2.4. Ethical consideration
The study protocol was approved by the departmental research
committee (chaired by Vice Dean) and deanship of scientiﬁc re-
search, King Faial University. Any information that discloses
the name of the pharmacist was avoided. The names of the of
community pharmacy were only noted to distinguish between
the chain and independent pharmacies and are not disclosed
in any form that may label the image of the pharmacy.
2.5. Data analysis
The demographics of the community pharmacist were calcu-
lated through descriptive statistics using Statistical Package
for Social Sciences SPSS 13. A parametric statistics (ANO-
VA and independent sample t-test) was applied to see the dif-
ferences among the groups based on score. p-Values <0.05
were considered statistically signiﬁcant.
3. Results
Total of N= 74 pharmacists were approached, of whom three
have refused. One of these three mentioned that he is busy and
cannot explain about it now, the second one mentioned that thedf F/t p
62 2.851 0.009*
62 2.325 0.003*
68 1.226 0.226
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said that there is nothing to explain about it. Finally, 71 phar-
macists were assessed during this study. Analysis of data re-
vealed that only one of the pharmacists assessed during this
study was Saudi. Nearly all the pharmacists working on the
community pharmacies were Egyptians 70 (98.6%). About
37 (52.1%) of the pharmacists were from the chain pharmacies
while other 34 (47.9%) were from the individual/independent
pharmacies. A higher number of the pharmacists were from
the middle age (36–40 years) with a mean age of
38.74 ± 4.52. The entire pharmacists were having a bachelor
degree in pharmacy and majority of them 40 (56.3%) having
an experience of about 9–10 years. Details about the demo-
graphics of the pharmacist are shown in Table 1.
When the assessment criterion was applied, it was seen that
only four steps were demonstrated commonly by the majority
of 57–75% of the pharmacists. These steps are; breathe the air
slowly out of the lungs, tilt back your head slightly, place the
inhaler mouthpiece in the upright position and close the lips
and breathe in slowly for 3–5 s (Table 2). Scoring of the re-
sponses revealed that nearly all possess a moderate level of
knowledge about the appropriate use of inhalers. As a whole,
mean score for the pharmacists was 4.2 ± 2.08. Details about
the knowledge score as per the pharmacist demographics are
shown in Table 3.4. Discussion
Treatment outcomes for the asthmatic patients are widely
dependent on the appropriate use of inhalers (Al-Hassan,
2009). Poor understanding of the patients with the appropriate
use of inhalers means that they lack proper education or coun-
seling by the health care provider to use inhalers. Pharmacists
are the one responsible to educate the patients about the crit-
ical steps that must be followed while using an inhaler (Al-
Hassan, 2009). However, if the pharmacist is not knowledge-
able, then the patients will remain deprived of the right method
to use an inhaler. The current study is one such effort to assess
community pharmacist knowledge about the essential steps for
inhaler use. Findings of the current study demonstrate a poor
knowledge among the majority of community pharmacists to-
ward the critical steps during the inhaler use. Only 29.58% of
the pharmacists has explained to breathe out before taking a
puff. Similarly deep inhalation after the puff is explained by
45.07% of the respondents. Final evaluation has shown a mod-
erate knowledge among the community pharmacist towards
the appropriate use of inhalers. Those pharmacists aged 30–
35 years were found to have a signiﬁcantly (5.52 ± 2.14,
t= 2.851, p= 0.009*) higher knowledge about the appropri-
ate use of inhalers. In addition, job experience (3–4 years)
was found signiﬁcantly (p= 0.003*) associated with a better
knowledge toward the appropriate use of inhalers. Similarly,
those pharmacists working on chain pharmacies were found
more knowledgeable than the pharmacists working on inde-
pendent pharmacies. These ﬁndings comply with the interna-
tional studies that report pharmacist’s deﬁcient knowledge in
explaining the patient about the correct inhaler use (Chopra
et al., 2002; Basheti et al., 2005). Poor skills to use inhalers will
decrease the conﬁdence level among the community pharma-
cists and may result in the provision of incorrect instruction
to the asthma patient. In addition, it is possible that due towrong inhalation techniques, the patient is under dosed and
therapeutic objectives are not achieved. Keeping in view the
patient condition the physician may advise a higher dose that
may increase the direct cost with a higher probability of side
effects.
5. Limitation
Most of the community pharmacists approached were Egyp-
tians; therefore, the ﬁnding of this study cannot be generalized
for the Saudi pharmacists.6. Conclusion
Pharmacists working on community pharmacies in Alahsa re-
gion were not aware of the correct way to use inhalers. It was
seen that the young pharmacists working on chain pharmacies
have comparatively better knowledge than the other groups.7. Recommendations
This study was conducted only in one city in the eastern region
of Saudi Arabia. Studies with large sample sizes should be per-
formed to address this issue nationwide. Furthermore, the reg-
ulatory and licensing authorities should assess the skills of the
community pharmacist in the use of metered dose drug deliv-
ery devices before giving license to practice.Acknowledgement
We would like to thank the 2nd year Pharm D students for
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